Data from recent medical trials in Africa show that the lives of nearly 200,000 people could be saved annually if countries with high rates of malaria treated patients with a pricier, yet more effective drug. The medical charity Medecins Sans Frontieres today said the drug, artesunate, was not only better, but easier to use than quinine, a cheaper medicine commonly used in poor countries.

Full Story:

Related Summaries